Yanqin Qin

637 total citations
18 papers, 493 citations indexed

About

Yanqin Qin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Yanqin Qin has authored 18 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Yanqin Qin's work include Cancer-related molecular mechanisms research (5 papers), Neonatal Respiratory Health Research (4 papers) and Medicinal Plant Pharmacodynamics Research (3 papers). Yanqin Qin is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Neonatal Respiratory Health Research (4 papers) and Medicinal Plant Pharmacodynamics Research (3 papers). Yanqin Qin collaborates with scholars based in China, United States and Australia. Yanqin Qin's co-authors include Jiansheng Li, Peng Zhao, Xuefang Liu, Suxiang Feng, Yange Tian, Yulong Chen, Haoran Dong, Suyavaran Arumugam, Xinshou Ouyang and Yaosong Wu and has published in prestigious journals such as Cell Death and Differentiation, Cell Reports and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Yanqin Qin

18 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanqin Qin China 10 250 112 103 88 41 18 493
Zunyong Feng China 14 342 1.4× 147 1.3× 78 0.8× 118 1.3× 47 1.1× 21 558
Mingjun Chen China 9 205 0.8× 51 0.5× 90 0.9× 60 0.7× 37 0.9× 20 413
Shui-juan Zhang China 17 250 1.0× 71 0.6× 107 1.0× 43 0.5× 34 0.8× 26 525
Xueyi Zhu China 12 178 0.7× 107 1.0× 119 1.2× 87 1.0× 42 1.0× 20 474
La Yi China 13 201 0.8× 106 0.9× 144 1.4× 88 1.0× 46 1.1× 20 496
Kaikai Yu China 10 229 0.9× 111 1.0× 76 0.7× 80 0.9× 43 1.0× 22 440
Tulake Wuniqiemu China 11 160 0.6× 92 0.8× 102 1.0× 64 0.7× 41 1.0× 16 416
Peiwu Li China 17 309 1.2× 70 0.6× 114 1.1× 175 2.0× 45 1.1× 37 659
Zhihui Zhang China 10 234 0.9× 57 0.5× 149 1.4× 37 0.4× 43 1.0× 25 519
Kamal Hezam China 10 207 0.8× 69 0.6× 77 0.7× 54 0.6× 58 1.4× 21 528

Countries citing papers authored by Yanqin Qin

Since Specialization
Citations

This map shows the geographic impact of Yanqin Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqin Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqin Qin more than expected).

Fields of papers citing papers by Yanqin Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanqin Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqin Qin. The network helps show where Yanqin Qin may publish in the future.

Co-authorship network of co-authors of Yanqin Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Yanqin Qin. A scholar is included among the top collaborators of Yanqin Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanqin Qin. Yanqin Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Qin, Yanqin, et al.. (2024). Recent advances in the therapeutic potential of nobiletin against respiratory diseases. Phytomedicine. 128. 155506–155506. 13 indexed citations
2.
Qin, Yanqin, et al.. (2024). Investigating the anti-inflammatory effects of icariin: A combined meta-analysis and machine learning study. Heliyon. 10(15). e35307–e35307. 2 indexed citations
3.
Qin, Yanqin, Haibo Li, Yange Tian, et al.. (2023). Effective-component compatibility of Bufei Yishen formula alleviates chronic obstructive pulmonary disease inflammation by regulating GSK3β-mediated NLRP3 inflammasome activation. Biomedicine & Pharmacotherapy. 168. 115614–115614. 5 indexed citations
4.
Arumugam, Suyavaran, Yanqin Qin, Ziwen Liang, et al.. (2022). GSK3β mediates the spatiotemporal dynamics of NLRP3 inflammasome activation. Cell Death and Differentiation. 29(10). 2060–2069. 35 indexed citations
5.
Shen, Lingqin, Xinyue Chen, Yanqin Qin, et al.. (2022). The support influence of Au‐based catalysts in glycerin selective oxidation to glyceric acid. Journal of Chemical Technology & Biotechnology. 98(1). 179–187. 5 indexed citations
6.
Qin, Yanqin, Miaomiao Yan, Bo Wang, et al.. (2022). Network Pharmacology and Experimental Validation to Reveal Effects and Mechanisms of Icariin Combined with Nobiletin against Chronic Obstructive Pulmonary Diseases. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 5 indexed citations
7.
Li, Jiansheng, et al.. (2021). The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD. Frontiers in Pharmacology. 12. 709702–709702. 27 indexed citations
8.
Qin, Yanqin, Binghua Li, Suyavaran Arumugam, et al.. (2021). m6A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity. Cell Reports. 37(6). 109968–109968. 83 indexed citations
9.
Li, Jiansheng, Yang Xie, Peng Zhao, et al.. (2021). A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38. Phytomedicine. 83. 153475–153475. 33 indexed citations
10.
Liu, Lan, Yanqin Qin, Yange Tian, et al.. (2021). Effective-components combination improves airway remodeling in COPD rats by suppressing M2 macrophage polarization via the inhibition of mTORC2 activity. Phytomedicine. 92. 153759–153759. 30 indexed citations
11.
12.
Li, Jiansheng, Yanqin Qin, Yulong Chen, et al.. (2020). Mechanisms of the lipopolysaccharide‑induced inflammatory response in alveolar epithelial cell/macrophage co‑culture. Experimental and Therapeutic Medicine. 20(5). 1–1. 30 indexed citations
13.
Zhao, Peng, Suyavaran Arumugam, Muhammad Nadeem Yousaf, et al.. (2019). Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 317(4). G387–G397. 35 indexed citations
14.
Chen, Yulong, Yaosong Wu, Suxiang Feng, et al.. (2019). Three Tiaobu Feishen therapies protect human alveolar epithelial cells against cigarette smoking and tumor necrosis factor--induced inflammation by nuclear factor-kappa B pathway.. PubMed. 39(1). 45–49. 4 indexed citations
15.
Li, Jiansheng, Peng Zhao, Ya Li, et al.. (2018). A Chinese Herbal Formula Ameliorates Pulmonary Fibrosis by Inhibiting Oxidative Stress via Upregulating Nrf2. Frontiers in Pharmacology. 9. 628–628. 39 indexed citations
16.
Liu, Xuefang, Yulong Chen, Yaosong Wu, et al.. (2018). LPS‑induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF‑κB, STAT3 or AP‑1 activation. Molecular Medicine Reports. 17(4). 5484–5491. 139 indexed citations
17.
Qin, Yanqin, Yulong Chen, & Jiansheng Li. (2016). [Research progress of cell co-culture method].. PubMed. 28(8). 765–8. 2 indexed citations
18.
Ren, Xiaodong, et al.. (2010). The extraction and analysis of evaluation object and emotion based on multi-stage scan. 35. V13–244. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zunyong Feng Breakdown of academic impact, for papers by Mingjun Chen Breakdown of academic impact, for papers by Shui-juan Zhang Breakdown of academic impact, for papers by Xueyi Zhu Breakdown of academic impact, for papers by La Yi Breakdown of academic impact, for papers by Kaikai Yu Breakdown of academic impact, for papers by Tulake Wuniqiemu Breakdown of academic impact, for papers by Peiwu Li Breakdown of academic impact, for papers by Zhihui Zhang Breakdown of academic impact, for papers by Kamal Hezam
Rankless by CCL
2026